Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I

A Study of the Effects of Marine Protein Hydrolysate as Dietary Supplement on the Regulation of Postprandial Blood Glucose Metabolism in Healthy Subjects

The aim of this study is to investigate the potential effect of a marine protein hydrolysate (MPH) supplement before a meal on postprandial glucose tolerance in healthy subjects, to achieve more knowledge on this presumed beneficial, blood glucose lowering effect

To further investigate the effects of MPH in a single dose of 20 mg/kg of body weight on postprandial blood glucose, insulin and GLP-1 (as markers of glucose metabolism) in healthy, active middle-aged to elderly subjects - age 40-65 years.

Inclusion Criteria:

• Signed informed consent
• Body mass index (BMI) 20-30

Exclusion Criteria:

• Suspected allergies against fish or shellfish
• Low or unstable blood pressure
• Diabetes mellitus, treated pharmacological
• Chronic diseases or therapies that is likely to interfere with the evaluation of study results
• Acute infections (may be reconsidered for inclusion at a later time)
• Allergic to milk, confirmed diagnose
• Pregnancy
• Women who are breast-feeding infants
• Inability or unwillingness to comply with the requirements of study procedures